Neocef (Cefixime)

Cefixime inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, which blocks the cross‑linking of peptidoglycan strands. This weakens the cell wall, causing osmotic lysis of susceptible Gram‑negative and some Gram‑positive bacteria, thereby clearing the infection.

The dosage of Neocef is determined by the prescribing clinician according to the patient’s age, weight, renal function and the specific infection being treated. Typical adult regimens range from 200 mg to 400 mg once daily, but the exact dose and duration must be individualized by a healthcare provider.

Safety data for cefixime in pregnancy are limited. It is classified as a pregnancy‑category unknown, so the prescriber must evaluate the potential benefits against any possible risks to the fetus. Cefixime is excreted in breast milk in small amounts; breastfeeding mothers should consult their physician before use.

To request Neocef, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Cefixime belongs to the third‑generation cephalosporin class, offering broader Gram‑negative coverage than first‑generation agents such as amoxicillin. Compared with azithromycin, cefixime is less active against atypical organisms but provides a convenient once‑daily oral regimen for many common bacterial infections.

Neocef should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in damp or excessively hot environments.

Neocef is taken orally, usually with a full glass of water. It may be taken with or without food, but if antacids are used, they should be spaced at least two hours apart to avoid reduced absorption. Follow the prescribing clinician’s instructions for timing and duration.

Serious adverse events include Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, hepatic injury, and hematologic abnormalities like neutropenia or thrombocytopenia. Patients should seek immediate medical attention if they experience persistent diarrhea, rash, swelling, or unusual bleeding.

Neocef is contraindicated in individuals with a known hypersensitivity to cefixime, other cephalosporins, or any component of the formulation. Patients with a history of severe allergic reactions to beta‑lactam antibiotics should avoid its use, and clinicians should assess renal function before prescribing.